Urea Cream 40%

Introduction Overview

Generic Name

Urea Cream 40%

Brand Name

Urea Cream

Dosage Form

Topical cream

Drug Class

Topical emollients

Pharmacokinetics

Pharmacokinetics of topical urea has not been fully characterized due to its localized site of action and minimal systemic absorption. However, the pharmacokinetic profile can be inferred based on the physicochemical properties of urea and its interaction with the skin.

Absorption: When applied topically in cream form, urea exhibits minimal systemic absorption. Its small molecular size and hydrophilic nature facilitate penetration into the stratum corneum where it exerts its local keratolytic effects. The cream base enhances hydration of the stratum corneum, increasing permeability and penetration of urea into hyperkeratotic skin. Absorption beyond the epidermis into systemic circulation is negligible, minimizing systemic exposure and toxicity risks.

Distribution: Following topical application, urea distributes primarily within the epidermis, particularly in the stratum corneum and upper layers of the epidermis where hyperkeratosis occurs. Urea acts locally to dissolve the intercellular matrix, softening thickened keratinized skin. Because systemic absorption is minimal, distribution to other tissues or organs is inconsequential.

Metabolism: Locally applied urea is not metabolized by skin enzymes but functions by disrupting hydrogen bonds between keratin molecules leading to denaturation and hydration of skin proteins. Any absorbed urea, which is minimal, would be subject to renal excretion unchanged as urea is a normal endogenous metabolite.

Elimination: Due to negligible systemic absorption, elimination following topical application is not clinically significant. In systemic pharmacology, urea is eliminated almost entirely by renal excretion. For topically applied urea, any absorbed amount is expected to be excreted unchanged in urine via the kidneys, but topical use limits systemic exposure to trace amounts.

Dosage Forms

Available Dosage Forms:
- Urea Cream 40% in multiple packaging sizes:
- 1 oz (28.35 g) cream
- 3 oz (85 g) cream
- 7 oz (198.4 g) cream

These are supplied in plastic bottles for topical application.

Dosages for Adults and Adolescents:
- Apply Urea 40% cream sparingly to affected skin areas twice daily or as directed by a physician.
- For diseased, ingrown, or devitalized nails, apply twice daily or per physician instructions.
- Rub cream until completely absorbed into skin or nail.

Specific Patient Populations:
- Pregnancy Category B; caution advised due to limited human data, prescribed only if clearly needed.
- Nursing mothers should exercise caution when applying due to unknown excretion in milk.
- Should be used only under physician guidance, particularly in patients with hypersensitivity or sensitive skin conditions.
- Not intended for ophthalmic use or application on mucous membranes.

Clinical guidelines emphasize using the lowest effective dose to minimize irritation, with monitoring for signs of adverse reactions.

Mechanism Of Action

Urea acts as a potent keratolytic agent when applied topically, exhibiting a unique mode of action compared to other topical emollients. The primary molecular mechanism involves the solubilization and disruption of hydrogen bonds within the intracellular matrix of the stratum corneum. By breaking these bonds, urea softens hardened keratinocytes, promotes hydration of the skin, and facilitates the shedding of thickened, scaly skin layers.

At the cellular level, urea enhances skin moisture retention by increasing water-binding capacity within the keratin matrix, thus improving the skin's barrier function and elasticity. This hydration effect also promotes enzymatic degradation of hyperkeratotic tissue, accelerating renewal and healing.

Biochemically, urea's small, hydrophilic molecule penetrates the stratum corneum and loosens intercellular cohesion without damaging viable tissue beneath. Unlike corticosteroids or immunomodulatory agents, urea does not suppress inflammation but aids mechanical debridement of necrotic or thickened skin, creating a more favorable microenvironment for skin repair.

Clinically, these effects manifest as reduction of roughness, scaling, and hyperkeratosis in conditions such as psoriasis, eczema, ichthyosis, and keratosis pilaris. Comparative studies show urea's synergistic potential when combined with other treatments due to its hydration and keratolytic properties. The mechanism is supported by numerous in vitro and clinical studies demonstrating improved skin softness, elasticity, and accelerated desquamation following urea application.

Pharmacological Actions

Keratolytic activity through disruption of hydrogen bonds in keratinized cells.
Hydrating and moisturizing effects by increasing water-binding in the stratum corneum.
Softening hyperkeratotic and thickened skin tissues to promote desquamation.
Facilitates removal of necrotic tissue and debris in impaired wound healing.
Non-immunosuppressive topical emollient action supporting skin barrier repair.
Promotes normal healing of skin lesions by debridement of hardened scales.
Improves skin elasticity and flexibility by enhancing moisture retention.
Localized topical effect with minimal systemic absorption or toxicity risk.
Aids in treatment of nail dystrophies such as ingrown or devitalized nails.
Enhances penetration of concomitant topical agents by modifying the skin surface.
Mild irritant effects stimulate local circulation and skin renewal processes.

Therapeutic Or Clinical Uses

Treatment of hyperkeratotic skin conditions including dry, rough skin.
Management of dermatological disorders such as psoriasis and eczema.
Treatment of ichthyosis and xerosis to restore skin hydration and texture.
Resolution of keratosis pilaris, keratosis palmaris, and keratoderma.
Debridement and softening of corns and plantar calluses to aid removal.
Treatment of damaged, ingrown, and devitalized nails to improve health.
Facilitation of healing in wounds complicated by necrotic or fibrinous debris.
Use as a supportive emollient in chronic dermatological conditions causing scaling.
Adjunctive therapy to improve skin pliability in thickened plaques.
Palliative care to reduce skin discomfort, itching, and irritation associated with scaling.
Promotion of normal desquamation process in various keratotic dermatoses.
Off-label use for loosening thickened skin prior to dermatological procedures.

Side Or Adverse Effects

Transient stinging sensations at application site.
Mild burning or tingling feelings upon first use.
Localized itching or pruritus which typically resolves with discontinuation.
Skin irritation including redness or erythema in sensitive individuals.
Potential for allergic contact dermatitis in patients with ingredient hypersensitivity.
Dryness or peeling if overused or applied to broken skin surfaces.
Rare reports of swelling or rash at application site.
No reported systemic adverse effects due to minimal absorption.
Discontinuation recommended if persistent irritation occurs.
Photosensitivity reactions not commonly associated but caution advised.
No known ocular toxicity but contact with eyes causes irritation.
Hypersensitivity reactions limited to topical exposure, reversible on cessation.
No systemic toxicities documented in pregnancy or nursing when used topically.
Potential for secondary infection if applied on open wounds without medical supervision.

Precautions

Use only as directed by a healthcare professional to avoid misuse or overdosing.
Avoid application on broken, inflamed, or infected skin unless prescribed.
Discontinue use and seek medical advice if skin redness, swelling, or irritation develops.
Not for ophthalmic use; avoid contact with eyes, lips, and mucous membranes.
Caution advised in pregnant women; use only if benefit outweighs risk (Pregnancy Category B).
Use carefully in nursing mothers owing to unknown excretion in breast milk.
Patients with known hypersensitivity to urea or cream excipients should avoid use.
Not recommended for pediatric populations unless specifically prescribed.
Avoid concurrent use with other potentially irritating topical agents without physician approval.
Store at controlled room temperature (15°C-30°C), protect from freezing.
Do not ingest; for external use only to prevent systemic toxicity.
Ensure proper hand washing after application to avoid inadvertent contact.
Consult physician prior to use if taking systemic medications that affect skin integrity.
Use cautiously in patients with compromised skin barriers or chronic dermatoses.

Warnings

For topical use only; do not apply to eyes, lips, or mucous membranes.
Avoid use on open wounds or severely broken skin unless directed by a physician.
Immediate discontinuation recommended if signs of hypersensitivity reaction occur.
Not tested or approved by FDA for therapeutic equivalency; use is based on professional judgement.
Avoid excessive application to prevent irritation, peeling, or dryness.
Keep out of reach of children to prevent accidental ingestion or misuse.
May cause transient stinging or burning sensation upon application.
Use caution in patients prone to skin sensitivity or allergic reactions.
Pregnant or nursing women should use only if clearly necessary and prescribed.
Not suitable for ophthalmic conditions; accidental eye contact may cause irritation.
Do not apply under occlusive dressings unless directed to avoid increased absorption.
Avoid mixing with other topical medications without medical supervision.
Regular monitoring advised in chronic use to assess skin condition and detect adverse effects.
Consult healthcare provider prior to starting or stopping therapy.

Contraindication

Known hypersensitivity or allergy to urea or any cream excipients such as Ceteareth-6, Ceteareth-25, Cetyl Alcohol, Mineral Oil, Propylene Glycol, Sodium Hydroxide, Stearyl Alcohol, Xanthan Gum.
Open or infected wounds where topical application may exacerbate infection.
Use in ocular or mucous membrane conditions due to potential irritation.
Not indicated for systemic fungal or bacterial infections.
Use contraindicated in patients with dermal hypersensitivity reactions to similar topical emollients.
Avoid use in acute dermatitis with compromised skin barrier function unless under close medical supervision.
Not recommended for pediatric patients lacking specific expert guidance.
Contraindicated in patients with prior severe reactions to urea-containing products.
Do not use as an alternative for prescribed corticosteroid or immunomodulator therapies unless advised by physician.
Avoid use with known incompatibilities to cream excipients or preservatives.
Not indicated for cosmetic use in individuals allergic to vehicle components.
Avoid use if previous adverse skin reactions to moisturizing creams have occurred.
Contraindicated if underlying neoplastic skin conditions are present unless monitored.
Any unknown allergy-related conditions involving topical applications.

Drug Interactions

Minimal significant drug interactions due to localized topical action and negligible systemic absorption.
Potential for increased skin irritation if used concurrently with other keratolytic agents (e.g., salicylic acid, alpha-hydroxy acids).
Possible additive irritant effects when combined with topical corticosteroids or retinoids.
Caution advised using with topical immunomodulators to prevent barrier disruption.
No clinically significant systemic pharmacokinetic interactions reported.
Avoid applying over areas recently treated with photodynamic therapy or laser unless cleared by physician.
May augment penetration of other topically applied drugs due to keratolytic and moisturizing effects; monitor for enhanced side effects.
No known interactions with systemic pharmacologic agents given minimal systemic absorption.
Concurrent use with occlusive dressings may increase local absorption and risk of irritation.
Monitor for increased sensitivity if combined with topical antibiotics or antifungals on damaged skin.
No significant interactions with common systemic medications used to treat dermatological conditions.
Potential to alter skin flora environment when combined with antiseptics, warranted monitoring.
Use with caution alongside skin irritants to avoid compounding adverse skin reactions.
No documented interactions with systemic corticosteroids or immunosuppressants.

Preparations Of The Drug

Urea 40% topical cream supplied in plastic bottles.
Available package sizes: 1 oz (28.35 g), 3 oz (85 g), and 7 oz (198.4 g).
Contains inactive ingredients: Ceteareth-6, Ceteareth-25, Cetyl Alcohol, Mineral Oil, Propylene Glycol, Purified Water, Sodium Hydroxide, Stearyl Alcohol, Xanthan Gum.
Formulated to gently soften skin and nails with potent keratolytic action.
Non-occlusive moisturizing vehicle facilitating skin absorption and hydration.
Preserved to maintain stability and sterility during shelf life.
Stored at room temperature (15–30°C), protected from freezing and excessive heat.
Each gram contains 40% w/w urea as the active pharmaceutical ingredient.
Non-greasy cream base designed for ease of application and rapid absorption.
Packaging labeled with usage instructions, ingredient disclosure, and safety cautions.
Distributed by Major Pharmaceuticals with Rx-only restriction.
Not subjected to FDA therapeutic equivalency testing; prescription use only.
Supplied with package insert detailing dosing recommendations, safety, and pharmacology.
Labelling includes warnings for topical use only and avoidance of sensitive areas.
Available through prescription, ensuring professional medical supervision.